The surgical oncologist, a key figure in the treatment of cancer patients Published on 23/09/2024 The opinion of Surgical Oncology becomes fundamental in the multidisciplinary committees that determine the best treatment plan for a cancer patient, as is the case at MD Anderson Madrid - Hospiten.
Dr. Enrique Grande, appointed adjunct professor at the Genitourinary Medical Oncology Department of the University of Texas MD Anderson Cancer Center in Houston Published on 11/09/2024 The new associate professor at the Houston centre joins the group of MD Anderson Madrid - Hospiten physicians who share this academic title in its various categories.
Bispecific Antibodies: New Therapies to Prolong Survival and Improve Quality of Life for Multiple Myeloma Patients Published on 02/09/2024 The incidence of bone marrow disease accounts for 10% of haematological malignancies.
The figure of the cardiologist has become essential to successful completion of the onco-hematological treatment Published on 23/07/2024 Cardio-onco-hematology is an emerging discipline that focuses on a clinical spectrum of cardiovascular problems that can arise during, subsequent to and sometimes long after cancer treatment.
The lapse of time between contracting a human papillomavirus infection (HPV) and the onset of cancer can be up to 20 years Published on 01/07/2024 HPV is the most common sexually transmitted infection in Spain, and it is estimated that more than 80% of the sexually active population will contract the infection at some point in their lives. High risk HPV is responsible for 70% of precancerous lesions.
MD Anderson Madrid – Hospiten incorporates robotic surgery for the treatment of head and neck cancers Published on 20/06/2024 The Head and Neck Surgery Service at MD Anderson Madrid - Hospiten performs more than 300 operations a year.
Other skin cancer risk factors besides the sun Published on 12/06/2024 The skin is the largest organ of the body and we are tremendously exposed. However, early detection of melanoma increases the chances of cure by almost 97%.
The early detection of bladder cancer results in less invasive treatment with cure rates of 90% with long term survival Published on 23/05/2024 This is the fifth most commonly diagnosed tumour in Spain, with an incidence almost five times greater in men than in women.
Clinical trials, a therapeutic opportunity for the cancer patient Published on 20/05/2024 Since its launch, MD Anderson Madrid – Hospiten's Phase I Clinical Trials Unit has recruited 1,064 patients for participation in 373 clinical trials.
Experts in haematological diseases analyse the advances in mediastinum lymphomas Published on 26/04/2024 MD Anderson Madrid – Hospiten hosts the LXXXVIII Meeting of the SEAP Lymphoma Club, a conference for national and international experts to discuss advances in lymphoid pathology.